COVID 19

Advertisement
Feb 07 2025HEALTH

The Vaccine Cash Quest: Does money convince more people to get vaccinated?

People are often motivated by cash, even for something as important as vaccinations. In the case of COVID-19 vaccines, previous studies have shown that financial bonuses raise the number of people who get the shot. These studies concluded that the direct impact of cash incentives could be small but

reading time less than a minute
Feb 07 2025HEALTH

What Happens to Kids' Guts After COVID-19?

In the long run, the impact of COVID-19 on the guts of children is a big mystery. Kids continue to have issues with their GI tracts. They are still having stomach problems even after they have recovered from the virus. This is a part of what doctors call the postacute and chronic phases. The out

reading time less than a minute
Feb 07 2025HEALTH

Paxlovid: The Pill That Battles COVID-19

Paxlovid, a clever mix of nirmatrelvir and ritonavir, made headlines as it became the first approved oral treatment for those with mild-to-moderate COVID-19 symptoms. This combination is designed to tackle the virus with minimal fuss. Everything works quite well using two main actors in the body: t

reading time less than a minute
Feb 07 2025HEALTH

Working on the Frontlines: The Struggle of Substance Use Staff in Scotland

When you think about substance use services, you might not immediately consider the professionals working there. But these folks are fighting the good fight, and it's not great. We all know substance use is a huge problem, especially with rising death rates. We need a solid plan, and workers on the

reading time less than a minute
Feb 06 2025SCIENCE

“20 years of news Under The Lens: Spotlight on U. S. Risk ”

Over the past 20 years, news reports have given certain risky situations a special spotlight. This study looks at what makes some stories get more attention. To do this, researchers did something new. They used special tools, like topic modeling and time-series analysis. This involves analyzing a

reading time less than a minute
Feb 06 2025POLITICS

Realism over Ideals: The Path for Scientific Progress

In recent times, the federal government is expected to move towards a pragmatic approach in handling scientific matters. This shift aims to restore public confidence in government policies, which are rooted in science. The trust in government, especially science-based directives, has plummeted and h

reading time less than a minute
Feb 06 2025HEALTH

Tweets and Truths: How Experts and Others Spoke About COVID-19

During the COVID-19 pandemic, experts and others used Twitter to share crucial information with the public. The pandemic was a time of uncertainty. Communication became crucial. Public health experts (PHEs) needed to share information and engage with people. At the same time, others also us

reading time less than a minute
Feb 05 2025ENVIRONMENT

Breathe Easy: What Happened To Pollution Levels in Five Indian Cities During Lockdowns?

Lockdowns forced a drastic change in the way cities breathed. This allowed a rare window to observe how air quality performs when humans stay indoors for long durations. Five big cities in India were tracked: Delhi on the north, Kolkata on the East, Bengaluru on the south, with Hyderabad and Visak

reading time less than a minute
Feb 04 2025HEALTH

Unveiling Long-Haul Effects of COVID-19

After COVID-19 patients recover, individuals can experience lasting conditions such as an intolerance to physical exertion for months, or even longer. Since COVID-19 first presented, research efforts to investigate these long-term implications have been of utmost priority. Adults who recovered fro

reading time less than a minute
Feb 03 2025BUSINESS

From Drugs to Solar Power: The Quantum Leap of Xtalpi

Xtalpi, a Hong Kong-listed company, is making waves in the tech world. It started with a bang in 2016. Wen Shuhao, the company's cofounder and chairman, and his team participated in a blind test. The challenge was to predict the 3D structure of molecules. These molecules show how effective a drug ca

reading time less than a minute